این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
صفحه اصلی
درباره پایگاه
فهرست سامانه ها
الزامات سامانه ها
فهرست سازمانی
تماس با ما
JCR 2016
جستجوی مقالات
جمعه 1 خرداد 1405
Tanaffos
، جلد ۲۴، شماره ۱، صفحات ۶۲-۶۸
عنوان فارسی
چکیده فارسی مقاله
کلیدواژههای فارسی مقاله
عنوان انگلیسی
Comparison between Levofloxacin and Azithromycin in Short-term Spirometry and Oxygen Saturation Indices in Patients with Exacerbated Bronchiectasis: A Randomized Double-blind Clinical Trial
چکیده انگلیسی مقاله
Background:
Bronchiectasis is a chronic pulmonary disease characterized by abnormal and permanent dilatation of the airways in the lung. This study was conducted to compare the effect of levofloxacin with azithromycin in improving the lung function of these patients.
Materials and Methods:
In this parallel double-blinded randomized clinical trial, 72 patients with exacerbated bronchiectasis were included and randomly divided into two intervention groups. One group was treated with levofloxacin (500 mg daily for two weeks at first and then 250 mg daily in the next four weeks), and the other group with azithromycin (500 mg daily in the first two weeks and then with a dose of 250 mg daily for the next four weeks) for 6 weeks. The pulmonary function tests were performed and analyzed at the beginning of the study, two, four, and six weeks after the intervention.
Results:
The mean expiratory volume in the first second (FEV1) and the percentage of oxygen saturation (
O
2
Sa
t) in the levofloxacin group and the azithromycin group were not significantly different at the beginning of the study. Importantly, six weeks after the initiation, the mean FEV1 (61.02±8.54% vs.
56.88±7.13%
, p=0.029) and
O
2
Sa
t (91.00±1.72% vs. 85.44±1.77%, p=0.001) in the levofloxacin group were significantly higher than those in the azithromycin group.
Conclusion:
The present study showed that the favorable effect of six-week therapy with levofloxacin compared to azithromycin can significantly increase the pulmonary values of FEV1 and
O
2
Sa
t in patients with exacerbated bronchiectasis.
کلیدواژههای انگلیسی مقاله
Levofloxacin,Azithromycin,Bronchiectasis,Respiratory function
نویسندگان مقاله
Maryam Hajimirghasemi |
Department of Respiratory, Faculty of Medicine, Shahroud University of Medical Science, Shahroud, Iran
Mahdi Behi |
Department of Pharmacology, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Hoofer Rafiei |
Department of Nephrology, Faculty of Medicine, Shahroud University of Medical Sciences, Shahroud, Iran
Mohammad Bagher Sohrabi |
Faculty of Medicine, Shahroud University of Medical Sciences, Shahroud, Iran
Babak Gholamine |
Department of Pharmacology, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Mahsa Forghani |
Department of Internal medicine, Faculty of Medicine, Shahroud University of Medical Science, Shahroud, Iran
نشانی اینترنتی
https://www.tanaffosjournal.ir/article_733721_81e5c6392e2feb14ddc49235f62ea737.pdf
فایل مقاله
فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده
en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
برگشت به:
صفحه اول پایگاه
|
نسخه مرتبط
|
نشریه مرتبط
|
فهرست نشریات